Predominant Expression of Type II Vasoactive Intestinal Peptide Receptors by Human T Lymphoblastoma Cells: Transduction of Both Ca2+ and Cyclic AMP Signals

Journal of Clinical Immunology

Volumn 16, Issue 1, 1996, Pages 21-30

  Xia, Menghang ^a   Sreedharan, Sunil P ^a   Goetzl, Edward J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

G protein receptor; Immunology; Neuropeptides

Indexed keywords

CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOBLASTOMA; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BINDING SITES; CALCIUM; CYCLIC AMP; HUMANS; LYMPHOMA, LYMPHOBLASTIC; MOLECULAR SEQUENCE DATA; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0030054187     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01540969     Document Type: Article

References (36)

1. Said SI: Vasoactive intestinal peptide. J Endocrinol Invest 9:191-200, 1986
2. Johnston JA, Taub DD, Lloyd AR, Conlon K, Oppenheim JJ, Kevlin DJ: Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J Immunol 153:1762-1769, 1994
3. Ottaway CA: In vitro alteration of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. J Exp Med 160:1054-1069, 1984
4. Matthew RC, Cook GA, Blum AM, Metwali A, Felman R, Weinstock JV: Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection. J Immunol 148:3572-3581, 1992
5. Boundard F, Bastide M: Inhibition of mouse T-cell proliferation by CGRP and VIP: Effects of these neuropeptides on IL-2 production and cAMP synthesis. J Neurosci Res 29:29-41, 1991
6. Sun L, Ganea D: Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex. J Neuroimmunol 48:59-70, 1993
7. Stanisz AM, Befus D, Bienenstock J: Differential effects of vasoactive intestinal peptide, substance P. and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 136:152-156, 1986
8. Rola-Pleszczynski MD, Bolduc D, Pierre SS: The effects of vasoactive intestinal peptide on human natural killer cell function. J Immunol 135:2569-2573, 1985
9. Staun-Olsen P, Ottesen B, Bartels PD, Nielsen MH, Gammeltoft S, Fahrenkrug J: Receptors for vasoactive intestinal polypeptide on isolated synaptosomes from rat cerebral cortex, heterogeneity of binding and desensitization of receptors. J Neurochem 39:1242-1251, 1982
10. Ottesen B, Staun-Olsen P, Gammeltoft S, Fahrenkrug J: Receptors for vasoactive intestinal peptide on crude smooth muscle membranes from porcine uterus. Endocrinology 110:2037-2043, 1982
11. Huang M, Rorstad UP: VIP receptors in mesenteric and coronary arteries: A radioligand binding study. Peptides 8:477-485, 1987
12. Danek AM, O'Dorisio MS, O'Dorisio TM, George JM: Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. J Immunol 131:1173-1177, 1983
13. Finch RJ, Sreedharan SP, Goetzl EJ: High-affinity receptors for vasoactive intestinal peptide on human myeloma cells. J Immunol 142:1977-1981, 1989
14. Rosselin G: The receptors of the VIP family peptides (VIP, secretin, GRP, PHI, PHM, GIP, glucagon and oxyntomodulin). Peptides 7 (Suppl 1):89-100, 1986
15. Sobel A, Tashjian AH Jr: Distinct patterns of cytoplasmic protein phosphorylation related to regulation of synthesis and release of prolactin by GH cells. J Biol Chem 258:10312-10324, 1983
16. Sreedharan SP, Patel DR, Xia M, Ichikawa S, Goetzl EJ: Human vasoactive intestinal peptide receptors expressed by stable translectants couple to two distinct signalling pathways. Biochem Biophys Res Commun 203:141-148, 1994
17. Audigier S, Bareris C, Jard S: Vasoactive intestinal polypeptide increases inositol phospholipid breakdown in the rat superior cervical ganglion. Brain Res 376:363-367, 1986
18. Fatatis T, Holtzclaw LA, Avidor R, Brenneman DE, Russell JT: Vasoactive intestinal peptide increases intracellular calcium in astroglia: Synergism with beta-adrenergic receptors. Proc Natl Acad Sci USA 91:2036-2040, 1994
19. Robberecht P, Waelbroek M, DeNeef P, Christophe J: A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts. FEBS Lett 228:351-355, 1989
20. Sreedharan SP, Patel DR, Huang JX, Goetzl EJ: Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem Biophys Res Commun 193: 546-553, 1993
21. Lutz LM, Sheward WJ, West KM, Morrow JA, Fink G, Harmar AJ: The VIP2 reeeptor: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett 334:3-8, 1993
22. Payan DG, Missirian-Bastian A, Goetzl FJ: Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. Proc Natl Acad Sci USA 81:3501-3505, 1984
23. 2+ channel activator, in cardiac and vascular preparations. Mol Pharmacol 40:734-741, 1991
24. An S, Yang J, Xia M, Goetzl EJ: Cloning and expression of the HP2-subtype of human receptors for prostaglandin E2. Biochem Biophys Res Commun 197:263-270, 1993
25. Munson PJ, Rodbard D: LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239, 1980
26. Ishihara TR, Shigemoto K, Mori K, Takahashi K, Nagata S: Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8:811-819, 1992
27. Christophe J, Chatelain P, Taton G, Delhaye M, Waelbroeck M, Robberecht P: Comparison of VIP-secretin receptors in rat and human lung. Peptides 2 (Suppl 2):253-258, 1981
28. Sakakibara H, Shima K, Said SI: Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages. Am J Physiol 267:L256-L262, 1994
29. Beed EA, O'Dorisio MS, O'Dorisio TM, Gaginella TS: Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts. Regul Pept 6:1-12, 1983
30. Wood CL, O'Dorisio MS: Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts. J Biol Chem 260:1243-1247, 1985
31. O'Dorisio MS, Shannon BT, Fleshman DJ, Campolito LB: Identification of high affinity receptors for vasoactive intestinal peptide on human lymphocytes of B cell lineage. J Immunol 142:3533-3536, 1989
32. Wiik P, Opstad P, Boyum A: Binding of vasoactive intestinal polypeptide (VIP) by human blood monocytes: Demonstration of specific binding sites. Regul Pept 12:145-153, 1985
33. Lefkowitz RJ, Stadel JM, Caron MG: Adenylate cyclase-coupled beta-adrenergic receptors: Structure and mechanisms of activation and desensitization. Annu Rev Biochem 52:159-186, 1983
34. Mao YK, Tougas G, Barnett W, Daniel EE: VIP receptors on canine submucosal synaptosomes. Peptides 14:1149-1152, 1993
35. Goldman DW, Chang FH, Gifford LA, Goetzl EJ, Bourne HR: Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes. J Exp Med 162:145-156, 1985
36. Anton PA, Shanahan F, Sun XP, Dieho D, Kodner A, Mayer EA: VIP modulates intracellular calcium oscillations in human lymphoblasts. Immunopharm Immunotox 15:429-446, 1993